N-acetyl-cysteine and Carbohydrate Metabolism Disorder in Obese Women
NCT ID: NCT03902327
Last Updated: 2020-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2020-01-17
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Fatty Acid Composition and Obesity-related Metabolic Abnormalities
NCT01451970
The Effect of Oral Iron Supplements on Insulin and Glucose Metabolism in Overweight and Obese Women
NCT07315282
Metabolic Effects of Oral Sodium Butyrate Supplementation on Overweight Individuals
NCT06247020
Beta-glucan and Insulin Sensitivity in Obese Humans
NCT01393210
Insulin Resistance Study
NCT00614757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NAC group
NAC for 12 weeks, 1.6 mg/day, 4x400 mg; a diet based on general recommendations for people with carbohydrate metabolism disorder
NAC group
Nutrition intervention focused on the treatment of carbohydrate metabolism disorder + N - acetylocysteine supplementation (1600 mg /d, 400 mg x 4 times a day)(30 people).
Control group
Placebo for 12 weeks and a diet based on general recommendations for people with carbohydrate metabolism disorder
Control group
Nutrition intervention focused on the treatment of carbohydrate metabolism disorder + placebo (4 times a day) (30 people).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NAC group
Nutrition intervention focused on the treatment of carbohydrate metabolism disorder + N - acetylocysteine supplementation (1600 mg /d, 400 mg x 4 times a day)(30 people).
Control group
Nutrition intervention focused on the treatment of carbohydrate metabolism disorder + placebo (4 times a day) (30 people).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* obesity (BMI \>29,9 kg/m2)
* patients not participating in other similar research programs at the same time,
* written agreement to take part in the research.
Exclusion Criteria
* failure to comply with dietary recommendations established during the nutritional intervention,
* pregnancy and breast feeding.
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poznan University of Life Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Agata Chmurzyńska
dr hab, Director of Institute of Human Nutrition and Dietetics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Poznan University of Life Sciences
Poznan, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PoznanULS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.